Durable Response With Sequential Tyrosine Kinase Inhibitor Treatment in a Patient With ROS1 Fusion-Positive Pancreatic Adenocarcinoma: A Case Report

JCO Precis Oncol. 2023 Apr:7:e2200467. doi: 10.1200/PO.22.00467.

¹ Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Lung Cancer Group Cologne, University of Cologne, Cologne, Germany.
² Department of Pathology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
³ Faculty of Medicine and University Hospital Cologne, Institute for Diagnostic and Interventional Radiology, University of Cologne, Cologne, Germany.
⁴ Practice for Clinical Hematology and Oncology, Frechen, Germany.
⁵ Department of Gastroenterology and Hepatology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
⁶ Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.

No abstract available

Publication types